Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
Triad Group PLC
LSE:TRD
|
UK |
Shareholder Yield
Current shareholder yield for
CRNX is
.
Peers Comparison
Shareholder Yield
Price Appreciation
CRNX Price
Crinetics Pharmaceuticals Inc
| Average Annual Return | 42.14% |
| Standard Deviation of Annual Returns | 56.07% |
| Max Drawdown | -58% |
| Market Capitalization | 3.8B USD |
| Shares Outstanding | 104 710 000 |
| Percentage of Shares Shorted | 16.46% |